← Home / Relay Therapeutics, Inc. (RLAY)
Stock Analysis
Relay Therapeutics, Inc. (RLAY)
RLAY
RLAY · Market data
19.44 -2.36%
Track RLAY in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when RLAY price is:
52W Range Position
93%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-07-20 18:49 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 20.75. Holding above 16.63 keeps the current thesis intact.
⚖️
✓
Fundamentals
Weak / Negative
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
16.63
↗
Break Above
Confirmation improves above resistance.
20.75
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 16.63
What's Driving RLAY?
📈 Technical recovery is improving
Momentum is Neutral. Watch 20.75 for confirmation and 16.63 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 16.63
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
59.0
Price Chart
RLAY · WOI overlay chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-17
Spec
Speculative premium
Valuation is very demanding relative to current fundamentals; expectations are high.
Market Cap
$3.8B
Company size
EV
$3.6B
Debt-adjusted value
P/E
-13.8
Not meaningful
P/B
5.9
Balanced
EV/EBIT
-12.0
Not meaningful
P/FCF
-17.6
Not meaningful
FCF Yield
-5.67%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Weak
●
Profitability
Negative
≈
Cash Flow
Recovering
⚖
Balance Sheet
Strong
💵 Revenue
3.00M
↘ Weak
📈 Net Income
-73.29M
↘ Negative
🧮 EPS (Basic)
-0.41
↘ Negative
Relay Therapeutics, Inc.
Related Opportunities